← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2013Last known activity
May 25, 2023
Timeline
1930s
- Jan 1, 1934
Weizmann Institute of Science— Founded
Drugs by trial phase (22 distinct, 21 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Indications
Recent trials (27)
- NCT05883397CollaboratorN/AMay 25, 2023
- NCT04707222Reponsible party - principal investigatorN/ADec 31, 2021
- NCT04707222Lead sponsorN/ADec 31, 2021
- NCT04707222Overall official - principal investigatorN/ADec 31, 2021
- NCT05024188CollaboratorN/ADec 1, 2021
- NCT05002153CollaboratorN/ANov 30, 2021
- NCT04697550Lead sponsorN/AOct 1, 2021
- NCT04697550Sponsor investigatorN/AOct 1, 2021
- NCT04697550Overall official - principal investigatorN/AOct 1, 2021
- NCT05019417CollaboratorPhase 2/Phase 3Jun 30, 2021
- NCT04633369Lead sponsorN/AApr 21, 2021
- NCT04633369Overall official - principal investigatorN/AApr 21, 2021
- NCT04813653CollaboratorPhase 1Apr 18, 2021
- NCT04840823CollaboratorPhase 1/Phase 2Mar 26, 2021
- NCT06003972CollaboratorPhase 2Jan 4, 2021
Details
- Founded
- Rehovot, IL Jan 1, 1934
- Last known activity
- May 25, 2023